✦ LIBER ✦

Prospective therapeutic studies in nephrolithiasis

✍ Scribed by D. K. Ackermann

Publisher: Springer-Verlag
Year: 1997
Tongue: English
Weight: 423 KB
Volume: 15
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf02201854

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceftriaxone associated nephrolithiasis:

Ceftriaxone associated nephrolithiasis: a prospective study in 284 children

✍ Masoumeh Mohkam; Abdollah Karimi; Atoosa Gharib; Hamid Daneshmand; Alireza Khata 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 155 KB

Pharmacogenomics and therapeutic prospec

Pharmacogenomics and therapeutic prospects in dementia

✍ Ramón Cacabelos 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 599 KB

Prognosis of coma after therapeutic hypo

Prognosis of coma after therapeutic hypothermia: A prospective cohort study

✍ Aline Bouwes; Jan M. Binnekade; Michael A. Kuiper; Frank H. Bosch; Durk F. Zands 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## Abstract ## Objective: This study was designed to establish the reliability of neurologic examination, neuron‐specific enolase (NSE), and median nerve somatosensory‐evoked potentials (SEPs) to predict poor outcome in patients treated with mild hypothermia after cardiopulmonary resuscitation (CP

Therapeutic studies in hepatic encephalo

Therapeutic studies in hepatic encephalopathy

✍ Kevin D. Mullen; Piero Amodio; Marsha Y. Morgan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 344 KB

Cefotaxime versus penicillin in the late

Cefotaxime versus penicillin in the late stage of lyme disease — prospective, randomized therapeutic study

✍ D. Hassler; L. Zöller; Martina Haude; H. G. Sonntag; H. D. Hufnage; F. Heinrich 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 879 KB

Complications of therapeutic plasma exch

Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures

✍ Douglas Shemin; Doris Briggs; Melanie Greenan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract The type and number of complications was prospectively examined in 1,727 successive TPE treatments in 174 patients over 66 months at a single center. Most treatments were prescribed for thrombotic thrombocytopenic purpura (TTP; 42%), recurrent focal segmental glomerulosclerosis (FSGS; 2